Bio-Techne Corporation
TECH
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 4 days ago • TECH
Bio-Techne's Q3 Earnings on Deck: What's in Store for the Stock?
PRNewsWire • 17 days ago • TECH
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
Zacks Investment Research • 18 days ago • TECH
BIIB or TECH: Which Is the Better Value Stock Right Now?
PRNewsWire • 19 days ago • TECH
Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
Zacks Investment Research • 20 days ago • TECH
All You Need to Know About Techne (TECH) Rating Upgrade to Buy
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.